This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Chris Oswald
Founder, Owner, and Principal Consultant at Coswald Consulting LLC


Chris is an independent consultant specializing in CMC related activities. His experience spans from developing oligo related analytical methods in the laboratory, to managing a commercial QC laboratory, and then transitioning into being the manufacturing plant manager for Agilent Technologies. These roles have provided him exposure to many CMC strategies that have been successfully utilized for clinical, pre-commercial, and commercial oligonucleotides in both the drug substance and drug product arenas. Chris also has a wide range of experience in facility buildouts, as well as the successful management of multiple DS and DP CMOs for multiple clients.

Agenda Sessions

  • Manufacturing and Scale-up at Light Speed - Producing and Scaling Up An Oligo to Save Lives Now!!